Nurse-led formal health review for immunosuppressed patients with uveitis.
OBJECTIVE
To describe and analyse a method of detailed formal health review for patients with sight-threatening uveitis using oral immunosuppression.


METHODS
Prospective clinical study of 37 patients.


RESULTS
Treatment side effects were absent or tolerable in 31 patients (84%) but 34 significant treatment side effects or other significant clinical findings were newly identified. Ten patients underwent a treatment change including three who transferred to a different immunosuppressive.


CONCLUSIONS
Formal health review has proved useful in identifying treatment side effects previously not volunteered by patients. A modified form is to be embedded within our clinic management system. We recommend such reviews to enhance drug safety in patients with sight-threatening chronic uveitis using oral immunosuppressives.
Jones
N P
NP
The Royal Eye Hospital, Manchester, Lancashire, UK. nicholas.jones@cmmc.nhs.uk
Pickford
M
M
D000284:Administration, Oral; D019090:Case Management; D002908:Chronic Disease; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D011446:Prospective Studies; D014605:Uveitis / Q000188:drug therapy* / Q000451:nursing
D007166:Immunosuppressive Agents